The company’s consolidated profit excluding minority interest dropped to EGP 105.826 million in January-September from EGP 46.728 million a year earlier ...
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
"Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients" was originally created and published by ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
GlobalData on MSN1d
Are dry powder inhalers the key to sustainable respiratory care?Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.
GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV ...
There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback